Accelerography in Neuromuscular Blockade Assessment

Technical Mechanism and Clinical Application

• Quantitative neuromuscular monitoring with acceleromyography is essential when administering neuromuscular blocking agents, and should be used throughout all phases of anesthesia, according to the American Society of Anesthesiologists 1
• The monitor must be activated after induction of general anesthesia but before neuromuscular blockade, as recommended by the American Society of Anesthesiologists 1
• The ulnar nerve with thumb adduction (adductor pollicis) is the most reliable monitoring site, as stated by the World Health Organization 1, 2

Train-of-Four Interpretation and Monitoring Protocol

• Four electrical stimuli are delivered in rapid succession, and with increasing neuromuscular blockade depth, twitches decrease progressively: T4 is lost first, then T3, T2, and finally T1, according to the American College of Surgeons 1
• The critical "monitoring gap" exists between TOF ratio 0.4 and 0.9—absence of visible fade only indicates recovery to 0.4 or greater, not adequate recovery, as noted by the American Society of Anesthesiologists 1
• A TOF ratio >0.9 must be documented before extubation to prevent residual paralysis complications, as recommended by the World Health Organization 1, 2

Important Limitations and Pitfalls

• If thumb movement is impeded (hand inaccessible during surgery), readings become unreliable with acceleromyography devices, according to the American Society of Anesthesiologists 1
• Patient factors that influence results include: monitoring site location, patient temperature, diaphoresis, peripheral edema, and skin resistance, as stated by the Society of Critical Care Medicine 3, 4
• Facial nerve monitoring increases the risk of residual paralysis five-fold compared to ulnar nerve monitoring—revert to ulnar nerve at surgery end, as recommended by the American Society of Anesthesiologists 1
• Response differs between adductor pollicis, orbicularis oculi, and respiratory muscles (chest wall/diaphragm) due to varying nicotinic receptor density, according to the Society of Critical Care Medicine 3, 4

Clinical Integration and Comprehensive Assessment

• Acceleromyography must be incorporated into a more comprehensive patient assessment that includes clinical evaluation—TOF monitoring alone should not determine adequacy of reversal, as stated by the Society of Critical Care Medicine 3, 5
• Clinical tests (sustained head-lift, hand grip, tongue depressor) have sensitivities of only 10-30% and cannot exclude residual blockade, according to the American Society of Anesthesiologists 1
• If acceleromyography is unreliable (hand inaccessible, excessive edema), consider electromyography devices or compressomyography (TOF-Cuff), as recommended by the American Society of Anesthesiologists 1
• Ultrasound guidance may help locate the ulnar nerve in patients with peripheral edema, according to the Society of Critical Care Medicine 3, 4

Impact of Muscle Relaxants on Neurological Assessment

Critical Impact on Clinical Assessment

• Muscle relaxant medications profoundly impair neurological assessment by eliminating the ability to evaluate motor function, muscle tone, and reflexes, making clinical neurological examination essentially impossible during active neuromuscular blockade, as stated by the American Society of Anesthesiologists 6, 7
• No clinical test is sensitive enough to detect residual neuromuscular blockade, rendering standard bedside neurological examination unreliable, according to the American Society of Anesthesiologists 6, 7
• Muscle tone assessment is unreliable during any degree of neuromuscular blockade, as reported by the American Society of Anesthesiologists 6, 7

The Assessment Gap During Paralysis

• Assessing pain, anxiety, and neurological status in patients receiving neuromuscular blocking agents is difficult, if not impossible, and clinicians must rely on indirect measures that lack specificity, as stated by the Society of Critical Care Medicine 8, 9
• Vital signs, such as heart rate and blood pressure, are not reliable indicators of pain or anxiety in patients receiving neuromuscular blocking agents, according to the Society of Critical Care Medicine 8, 9
• Diaphoresis and lacrimation lack specificity for neurological assessment in patients receiving neuromuscular blocking agents, as reported by the Society of Critical Care Medicine 8, 9

Quantitative Monitoring Requirements

• Only quantitative instrumental monitoring using train-of-four (TOF) ratio measurement at the adductor pollicis with supramaximal stimulation of the ulnar nerve can assess residual neuromuscular blockade, as stated by the American Society of Anesthesiologists 6, 7
• Clinical assessment alone is insufficient to determine the adequacy of reversal of neuromuscular blockade, according to the American Society of Anesthesiologists 6, 7

Consequences of Inadequate Assessment

• Residual neuromuscular blockade is associated with higher morbidity and mortality within the first 24 hours postoperatively, as reported by the American Society of Anesthesiologists 6, 7
• Patients with residual neuromuscular blockade are at greater risk of critical respiratory events in the recovery room, according to the American Society of Anesthesiologists 6, 7
• Residual neuromuscular blockade increases the risk of postoperative pneumonia, as stated by the American Society of Anesthesiologists 6, 7
• Residual neuromuscular blockade increases the risk of pharyngeal muscle dysfunction, according to the American Society of Anesthesiologists 6, 7
• Delayed discharge from the recovery room is a consequence of residual neuromuscular blockade, as reported by the American Society of Anesthesiologists 6, 7

Quantitative Train‑of‑Four (TOF) Monitoring and Evidence‑Based Reversal Strategies

Technical Requirements for Accurate TOF Monitoring

• Quantitative TOF monitoring must be performed at the adductor pollicis muscle using ulnar nerve stimulation; this is the only site validated for reliable assessment of residual neuromuscular blockade. 10
• Supramaximal stimulation intensity is required to ensure depolarisation of all nerve fibres. 10
• Acceleromyography or electromyography devices provide the objective quantitative measurements needed for clinical decision‑making. 10

Interpretation of TOF Ratios

• The TOF ratio is calculated as the amplitude of the fourth twitch divided by the amplitude of the first twitch (T4/T1). 10
• A TOF ratio ≥ 0.9 is the mandatory threshold for safe extubation and for preventing residual paralysis‑related complications. 10

Limitations of Clinical (Qualitative) Assessment

• Conventional clinical tests (sustained head‑lift, hand‑grip, tongue‑depressor) have low sensitivity—only 10‑30 %—for detecting residual neuromuscular blockade. 10

Depth of Blockade and Surgical Implications

• Deep blockade (no TOF responses but 1‑2 post‑tetanic count responses) enables a ≈ 25 % reduction in intra‑abdominal insufflation pressure during laparoscopic surgery compared with no blockade. 10

Neostigmine Reversal Guidelines

• Neostigmine must not be administered until at least four TOF responses are present; giving it with fewer responses is ineffective and predisposes to cholinergic side‑effects. 10
• When the “four‑response” rule is met, a dose of 0.04 mg kg⁻¹ neostigmine (with an anticholinergic such as glycopyrrolate 10 µg kg⁻¹) is recommended. Expected time to achieve TOF ≥ 0.9 is 10‑20 minutes, longer when sevoflurane is used for maintenance. 10
• Evidence: In a cohort of ≈ 160 patients receiving rocuronium, administration of neostigmine at 1‑3 TOF responses resulted in significantly prolonged recovery and failure to reach TOF ≥ 0.9 within 20 minutes; only administration at 4 responses yielded adequate recovery in the majority. (moderate‑quality observational data) 10

Clinical Consequences of Inadequate Monitoring

• Residual neuromuscular blockade (TOF < 0.9) is associated with higher 24‑hour postoperative morbidity and mortality, increased incidence of critical respiratory events, postoperative pneumonia, pharyngeal muscle dysfunction with aspiration risk, and delayed discharge from the recovery area. (association derived from guideline‑level evidence) 10

Rationale for Using the Adductor Pollicis as the Standard Site

• Different muscle groups recover at different rates because of varying nicotinic‑acetylcholine‑receptor densities: diaphragm and respiratory muscles recover fastest, pharyngeal muscles recover slowest, while the adductor pollicis recovers at an intermediate rate, making it the validated standard for quantitative monitoring. 10

Evidence‑Based Guidelines for Neuromuscular Blockade Monitoring Sites

Muscle Sensitivity and Monitoring Differences

• Muscle groups exhibit different sensitivities to neuromuscular blocking agents because of variations in nicotinic acetylcholine‑receptor density and regional blood flow, influencing onset and recovery patterns. 11
• The response to peripheral‑nerve stimulation differs markedly among the adductor pollicis, orbicularis oculi, and respiratory muscles (chest wall/diaphragm) owing to these receptor‑density differences. 11
• A train‑of‑four (TOF) count of 0/4 at one monitoring site does not guarantee absence of protective airway reflexes; cough response or intrinsic respiratory effort may still be present when other muscles are stimulated. 11

Recovery Assessment Prior to Extubation

• Monitoring the ulnar nerve with thumb adduction (adductor pollicis) is the only validated site for confirming adequate neuromuscular recovery before extubation. 12
• A quantitative TOF ratio ≥ 0.9 at the adductor pollicis must be documented before extubation to prevent residual paralysis and its associated complications. 12
• Quantitative techniques (acceleromyography or electromyography) should be employed to record the TOF ratio ≥ 0.9 at the adductor pollicis. 12
• The orbicularis oculi has a limited role limited to assessing optimal intubation timing during induction; it is not appropriate for recovery assessment before extubation. 12

Practical Monitoring Recommendations

• During the recovery phase, switch from facial‑muscle monitoring to ulnar‑nerve/adductor‑pollicis monitoring before considering extubation. 12

Patient Factors Affecting Monitoring Accuracy

• Peripheral edema can obscure external landmarks of the adductor pollicis; palpation of the ulnar artery or ultrasound guidance may be required to locate the ulnar nerve reliably. 11
• Patient temperature, diaphoresis, and skin resistance influence the accuracy of TOF monitoring at both facial and hand sites. 13